LXRX insider transactions
Lexicon Pharmaceuticals Inc. (LXRX) Form 4 insider transactions - real-time wire coverage of every officer, director, and 10% owner trade.
Recent Form 3, 4, and 5 filings for LXRX
- Director Swain Judith L converted options into 89,312 shares, increasing direct ownership by 105% to 174,486 units (SEC Form 4)4 - LEXICON PHARMACEUTICALS, INC. (0001062822) (Issuer)
- Director Sullivan Diane E. converted options into 89,312 shares, increasing direct ownership by 243% to 126,122 units (SEC Form 4)4 - LEXICON PHARMACEUTICALS, INC. (0001062822) (Issuer)
- Director Sobecki Christopher J converted options into 89,312 shares, increasing direct ownership by 44% to 293,177 units (SEC Form 4)4 - LEXICON PHARMACEUTICALS, INC. (0001062822) (Issuer)
- Director Cheung Ivan converted options into 89,312 shares (SEC Form 4)4 - LEXICON PHARMACEUTICALS, INC. (0001062822) (Issuer)
- Director Amouyal Philippe converted options into 89,312 shares, increasing direct ownership by 31% to 374,486 units (SEC Form 4)4 - LEXICON PHARMACEUTICALS, INC. (0001062822) (Issuer)
- Director Barker Sam L converted options into 89,312 shares, increasing direct ownership by 72% to 213,771 units (SEC Form 4)4 - LEXICON PHARMACEUTICALS, INC. (0001062822) (Issuer)
- Director Debbane Raymond converted options into 89,312 shares, increasing direct ownership by 5% to 1,995,498 units (SEC Form 4)4 - LEXICON PHARMACEUTICALS, INC. (0001062822) (Issuer)
- Director Artal Participations S.A R.L. converted options into 20,421,735 shares (SEC Form 4)4 - LEXICON PHARMACEUTICALS, INC. (0001062822) (Issuer)
- SEC Form 4 filed by Director Amouyal Philippe4 - LEXICON PHARMACEUTICALS, INC. (0001062822) (Issuer)
- SEC Form 4 filed by Director Sobecki Christopher J4 - LEXICON PHARMACEUTICALS, INC. (0001062822) (Issuer)
- SEC Form 4 filed by Director Barker Sam L4 - LEXICON PHARMACEUTICALS, INC. (0001062822) (Issuer)
- SEC Form 4 filed by Director Cheung Ivan4 - LEXICON PHARMACEUTICALS, INC. (0001062822) (Issuer)
- SEC Form 4 filed by Director Swain Judith L4 - LEXICON PHARMACEUTICALS, INC. (0001062822) (Issuer)
- SEC Form 4 filed by Director Sullivan Diane E.4 - LEXICON PHARMACEUTICALS, INC. (0001062822) (Issuer)
- SEC Form 4 filed by Director Debbane Raymond4 - LEXICON PHARMACEUTICALS, INC. (0001062822) (Issuer)
- SVP, Human Resources Mcdermott Wendy converted options into 224,406 shares and covered exercise/tax liability with 68,107 shares, increasing direct ownership by 128% to 277,945 units (SEC Form 4)4 - LEXICON PHARMACEUTICALS, INC. (0001062822) (Issuer)
- SVP, Partnerships & Corp Strat Martens Rachel Yap converted options into 67,090 shares and covered exercise/tax liability with 35,826 shares (SEC Form 4)4 - LEXICON PHARMACEUTICALS, INC. (0001062822) (Issuer)
- SVP, Chief Medical Officer Granowitz Craig B converted options into 312,276 shares and covered exercise/tax liability with 109,098 shares, increasing direct ownership by 169% to 323,430 units (SEC Form 4)4 - LEXICON PHARMACEUTICALS, INC. (0001062822) (Issuer)
- SVP, Discovery Gopinathan Suma converted options into 99,950 shares and covered exercise/tax liability with 24,338 shares, increasing direct ownership by 101% to 150,132 units (SEC Form 4)4 - LEXICON PHARMACEUTICALS, INC. (0001062822) (Issuer)
- SVP, IR and Corp Comm Defrancesco Lisa converted options into 152,864 shares and covered exercise/tax liability with 74,572 shares, increasing direct ownership by 503% to 93,869 units (SEC Form 4)4 - LEXICON PHARMACEUTICALS, INC. (0001062822) (Issuer)
- SVP, General Counsel & Secr. Crum Brian T converted options into 273,006 shares and covered exercise/tax liability with 105,019 shares, increasing direct ownership by 30% to 428,802 units (SEC Form 4)4 - LEXICON PHARMACEUTICALS, INC. (0001062822) (Issuer)
- SVP, Chief Financial Officer Coiante Scott M covered exercise/tax liability with 54,881 shares and converted options into 160,237 shares (SEC Form 4)4 - LEXICON PHARMACEUTICALS, INC. (0001062822) (Issuer)
- Chief Executive Officer Exton Michael covered exercise/tax liability with 204,831 shares and converted options into 503,263 shares (SEC Form 4)4 - LEXICON PHARMACEUTICALS, INC. (0001062822) (Issuer)
- Director Debbane Raymond bought $2,980 worth of shares (2,000 units at $1.49), increasing direct ownership by 0.11% to 1,906,186 units (SEC Form 4)4 - LEXICON PHARMACEUTICALS, INC. (0001062822) (Issuer)
- Director Debbane Raymond bought $147,000 worth of shares (100,000 units at $1.47), increasing direct ownership by 6% to 1,904,186 units (SEC Form 4)4 - LEXICON PHARMACEUTICALS, INC. (0001062822) (Issuer)
- Director Debbane Raymond bought $219,755 worth of shares (150,000 units at $1.47), increasing direct ownership by 9% to 1,804,186 units (SEC Form 4)4 - LEXICON PHARMACEUTICALS, INC. (0001062822) (Issuer)
- Director Artal Participations S.A R.L. was granted 41,290 units of Series B Convertible Preferred Stock (SEC Form 4)4 - LEXICON PHARMACEUTICALS, INC. (0001062822) (Issuer)
- Director Debbane Raymond bought $352,889 worth of shares (268,497 units at $1.31), increasing direct ownership by 19% to 1,654,186 units (SEC Form 4)4 - LEXICON PHARMACEUTICALS, INC. (0001062822) (Issuer)
- SEC Form 4 filed by SVP, Human Resources Mcdermott Wendy4 - LEXICON PHARMACEUTICALS, INC. (0001062822) (Issuer)
- SEC Form 4 filed by SVP, Partnerships & Corp Strat Martens Rachel Yap4 - LEXICON PHARMACEUTICALS, INC. (0001062822) (Issuer)
- SEC Form 4 filed by SVP, Chief Medical Officer Granowitz Craig B4 - LEXICON PHARMACEUTICALS, INC. (0001062822) (Issuer)
- SEC Form 4 filed by SVP, Discovery Gopinathan Suma4 - LEXICON PHARMACEUTICALS, INC. (0001062822) (Issuer)
- SEC Form 4 filed by SVP, IR and Corp Comm Defrancesco Lisa4 - LEXICON PHARMACEUTICALS, INC. (0001062822) (Issuer)
- SEC Form 4 filed by SVP, General Counsel & Secr. Crum Brian T4 - LEXICON PHARMACEUTICALS, INC. (0001062822) (Issuer)
- SEC Form 4 filed by SVP, Chief Financial Officer Coiante Scott M4 - LEXICON PHARMACEUTICALS, INC. (0001062822) (Issuer)
- SEC Form 4 filed by Chief Executive Officer Exton Michael4 - LEXICON PHARMACEUTICALS, INC. (0001062822) (Issuer)
- New insider Avicenna Life Sci Master Fund Lp claimed ownership of 1,538,462 shares (SEC Form 3)3 - LEXICON PHARMACEUTICALS, INC. (0001062822) (Issuer)
- Director Invus Global Management, Llc was granted 22,400,000 shares, bought $2,000,001 worth of shares (1,538,462 units at $1.30) and was granted 367,145 units of Series B Convertible Preferred Stock (SEC Form 4)4 - LEXICON PHARMACEUTICALS, INC. (0001062822) (Issuer)
- New insider Gopinathan Suma claimed ownership of 74,520 shares (SEC Form 3)3 - LEXICON PHARMACEUTICALS, INC. (0001062822) (Issuer)
- New insider Martens Rachel Yap claimed no ownership of stock in the company (SEC Form 3)3 - LEXICON PHARMACEUTICALS, INC. (0001062822) (Issuer)
- SEC Form 4 filed by Director Swain Judith L4 - LEXICON PHARMACEUTICALS, INC. (0001062822) (Issuer)
- SEC Form 4 filed by Director Sullivan Diane E.4 - LEXICON PHARMACEUTICALS, INC. (0001062822) (Issuer)
- SEC Form 4 filed by Director Sobecki Christopher J4 - LEXICON PHARMACEUTICALS, INC. (0001062822) (Issuer)
- SEC Form 4 filed by Director Cheung Ivan4 - LEXICON PHARMACEUTICALS, INC. (0001062822) (Issuer)
- SEC Form 4 filed by Director Barker Sam L4 - LEXICON PHARMACEUTICALS, INC. (0001062822) (Issuer)
- SEC Form 4 filed by Director Amouyal Philippe4 - LEXICON PHARMACEUTICALS, INC. (0001062822) (Issuer)
- SEC Form 4 filed by Director Debbane Raymond4 - LEXICON PHARMACEUTICALS, INC. (0001062822) (Issuer)
- Director Swain Judith L converted options into 36,810 shares, increasing direct ownership by 76% to 85,174 units (SEC Form 4)4 - LEXICON PHARMACEUTICALS, INC. (0001062822) (Issuer)
- Director Sullivan Diane E. converted options into 36,810 shares (SEC Form 4)4 - LEXICON PHARMACEUTICALS, INC. (0001062822) (Issuer)
- Director Sobecki Christopher J converted options into 36,810 shares, increasing direct ownership by 22% to 203,865 units (SEC Form 4)4 - LEXICON PHARMACEUTICALS, INC. (0001062822) (Issuer)
- Director Barker Sam L converted options into 36,810 shares, increasing direct ownership by 42% to 124,459 units (SEC Form 4)4 - LEXICON PHARMACEUTICALS, INC. (0001062822) (Issuer)
- Director Amouyal Philippe converted options into 36,810 shares, increasing direct ownership by 15% to 285,174 units (SEC Form 4)4 - LEXICON PHARMACEUTICALS, INC. (0001062822) (Issuer)
- Director Debbane Raymond converted options into 36,810 shares, increasing direct ownership by 3% to 1,385,689 units (SEC Form 4)4 - LEXICON PHARMACEUTICALS, INC. (0001062822) (Issuer)
- VP, Finance and Accounting Alexander Kristen converted options into 46,430 shares and covered exercise/tax liability with 17,862 shares, increasing direct ownership by 60% to 76,368 units (SEC Form 4)4 - LEXICON PHARMACEUTICALS, INC. (0001062822) (Issuer)
- SVP, Human Resources Mcdermott Wendy covered exercise/tax liability with 30,004 shares and converted options into 98,956 shares, increasing direct ownership by 131% to 121,646 units (SEC Form 4)4 - LEXICON PHARMACEUTICALS, INC. (0001062822) (Issuer)
- EVP, Innov & Chem Sciences Main Alan J converted options into 126,814 shares and covered exercise/tax liability with 43,434 shares, increasing direct ownership by 33% to 339,104 units (SEC Form 4)4 - LEXICON PHARMACEUTICALS, INC. (0001062822) (Issuer)
- SVP, Chief Medical Officer Granowitz Craig B converted options into 137,934 shares and covered exercise/tax liability with 65,308 shares, increasing direct ownership by 152% to 120,252 units (SEC Form 4)4 - LEXICON PHARMACEUTICALS, INC. (0001062822) (Issuer)
- SVP, IR and Corp Comm Defrancesco Lisa converted options into 24,673 shares and covered exercise/tax liability with 9,096 shares (SEC Form 4)4 - LEXICON PHARMACEUTICALS, INC. (0001062822) (Issuer)
- SVP, General Counsel & Secr. Crum Brian T converted options into 128,940 shares and covered exercise/tax liability with 45,622 shares, increasing direct ownership by 47% to 260,815 units (SEC Form 4)4 - LEXICON PHARMACEUTICALS, INC. (0001062822) (Issuer)
- SEC Form 4 filed by VP, Finance and Accounting Alexander Kristen4 - LEXICON PHARMACEUTICALS, INC. (0001062822) (Issuer)